Alexander Sproedt
Alex joined Xellia in November 2024 and serves as Chief Operations Officer, bringing more than a decade of experience across the Life Sciences industry, including Big Biopharma, Generics, Biotech, CDMO, and MedTech. Prior to Xellia, he spent 10 years at McKinsey & Company, where he became Partner in 2021.
Alex is driven by a clear ambition: to build high-performing operations that deliver results and enable innovation. With a strong focus on procurement, supply chain, and manufacturing, he is known for turning complexity into clarity and driving transformations that strengthen performance end-to-end.
He brings an energetic, forward-leaning mindset to leadership, creating momentum and pushing teams to aim higher.
For Alex, “Play to win” is more than a value - it’s a way of working: setting bold goals, focusing on what matters, and following through to achieve meaningful outcomes.
Alexander Sproedt
Alex joined Xellia in November 2024 and serves as Chief Operations Officer, bringing more than a decade of experience across the Life Sciences industry, including Big Biopharma, Generics, Biotech, CDMO, and MedTech. Prior to Xellia, he spent 10 years at McKinsey & Company, where he became Partner in 2021.
Alex is driven by a clear ambition: to build high-performing operations that deliver results and enable innovation. With a strong focus on procurement, supply chain, and manufacturing, he is known for turning complexity into clarity and driving transformations that strengthen performance end-to-end.
He brings an energetic, forward-leaning mindset to leadership, creating momentum and pushing teams to aim higher.
For Alex, “Play to win” is more than a value - it’s a way of working: setting bold goals, focusing on what matters, and following through to achieve meaningful outcomes.